Pharmacokinetic properties of a pasteurised fibrinogen concentrate
- 1 June 2005
- journal article
- research article
- Published by Elsevier in Transfusion and Apheresis Science
- Vol. 32 (3) , 239-246
- https://doi.org/10.1016/j.transci.2004.04.003
Abstract
No abstract availableKeywords
This publication has 28 references indexed in Scilit:
- Fibrinogen Gene Mutations Accounting for Congenital AfibrinogenemiaAnnals of the New York Academy of Sciences, 2001
- Molecular analysis of the fibrinogen gene cluster in 16 patients with congenital afibrinogenemia: novel truncating mutations in the FGA and FGG genesHuman Genetics, 2001
- COVALENT STRUCTURE OF FIBRINOGENAnnals of the New York Academy of Sciences, 1983
- Dimeric half-molecules of human fibrinogen are joined through disulfide bonds in an antiparallel orientationBiochemistry, 1983
- Fibrinogen AbnormalitiesSeminars in Thrombosis and Hemostasis, 1983
- Fibrin: Structure and InteractionsSeminars in Thrombosis and Hemostasis, 1982
- Disulfide Bridges in the Middle Part of Human FibrinogenHoppe-Seyler´s Zeitschrift Für Physiologische Chemie, 1978
- Formation of soluble fibrin polymers. Fibrinogen degradation fragments D and E fail to form soluble complexes with fibrin monomerBiochemistry, 1972
- Studies of the metabolism and distribution of fibrinogen in healthy men with autologous 125-I-labeled fibrinogen.Journal of Clinical Investigation, 1966
- Gerinnungsphysiologische Schnellmethode zur Bestimmung des FibrinogensActa Haematologica, 1957